Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × Valacyclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioma 2 Glioblastoma 2 Epstein-Barr Virus Infections 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Infectious Mononucleosis 1 Cytomegalovirus Infections 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Gemcitabine 311 Fluorouracil 78 Oxaliplatin 65 Capecitabine 61 Albumin-Bound Paclitaxel 58 130-nm albumin-bound paclitaxel 57 Radiotherapy 56 Leucovorin 45 Erlotinib Hydrochloride 43 Cisplatin 40 Irinotecan 39 Radiosurgery 29 Bevacizumab 27 Docetaxel 25 pembrolizumab 23 Taxes 22 Nivolumab 20 Cetuximab 19 Pancreaticoduodenectomy 16 Radiation 13 Drug Therapy 13 Cyclophosphamide 13 Endoscopic Ultrasound-Guided Fine Needle Aspiration 12 Neoadjuvant Therapy 11 irinotecan sucrosofate 10 folfirinox 10 Sorafenib 10 S 1 (combination) 10 Ipilimumab 10 Biopsy, Fine-Needle 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡